Santhera Pharmaceuticals Holding AG Stock Xetra
Equities
S3F
CH0027148649
Pharmaceuticals
Sales 2024 * | 51.09M 56.96M 52.75M 78.42M | Sales 2025 * | 60M 66.89M 61.94M 92.09M | Capitalization | 88.46M 98.63M 91.33M 136M |
---|---|---|---|---|---|
Net income 2024 * | -35M -39.02M -36.13M -53.72M | Net income 2025 * | -10M -11.15M -10.32M -15.35M | EV / Sales 2024 * | 1.73 x |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-3.42
x | P/E ratio 2025 * |
-12.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.98% |
Latest transcript on Santhera Pharmaceuticals Holding AG
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
1st Jan change | Capi. | |
---|---|---|
+18.88% | 80.5B | |
+14.11% | 9.15B | |
-14.14% | 4.9B | |
+43.39% | 4.49B | |
+18.90% | 4.44B | |
+7.93% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |